Furthermore, Nakagawa et al. demonstrated TGF-β1 expression levels vary among FECD patients based on their TCF4 trinucleotide repeat expansion status, suggesting a potential regulatory interplay between TCF4 and TGF-β signaling. Here, TGFB1 is linked to Fuchs endothelial corneal dystrophy.